Tremont AI Announces New Research Collaboration to Develop AI Models for Preclinical Safety Assessment
New research collaboration applies foundation models to building AI solutions for accelerated preclinical safety assessment. Tremont AI, an AI company specialized in preclinical drug safety, has announced a research collaboration with AstraZeneca to develop AI solutions for accelerated safety screening in pre-clinical toxicologic pathology studies. The collaboration aims to apply foundation models to building AI solutions to accelerated preclinical safety assessment. The company is exploring how foundation models can strengthen preclinical drugs safety assessment, freeing pathologists from repetitive review to focus on interpretation. Tremont AI is a Boston-based biomedical AI company that develops multimodal foundation models and integrated solutions to help pharmaceutical companies and contract research organizations make preclinical testing faster, more consistent, and more computable.
Yayınlanan : 6 saat önce ile içinde Health Tech Science
New research collaboration applies foundation models to building AI solutions for accelerated preclinical safety assessment.
BOSTON--(BUSINESS WIRE)--Tremont AI, an AI company specialized in preclini... [2499 symbols]
Konular: Data, AI
